These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 30008124)

  • 1. Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.
    Devanand DP
    Curr Neurol Neurosci Rep; 2018 Jul; 18(9):55. PubMed ID: 30008124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial.
    Devanand DP; Andrews H; Kreisl WC; Razlighi Q; Gershon A; Stern Y; Mintz A; Wisniewski T; Acosta E; Pollina J; Katsikoumbas M; Bell KL; Pelton GH; Deliyannides D; Prasad KM; Huey ED
    BMJ Open; 2020 Feb; 10(2):e032112. PubMed ID: 32034019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    Powell-Doherty RD; Abbott ARN; Nelson LA; Bertke AS
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1.
    Wozniak MA; Frost AL; Preston CM; Itzhaki RF
    PLoS One; 2011; 6(10):e25152. PubMed ID: 22003387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.
    Kobayashi N; Nagata T; Shinagawa S; Oka N; Shimada K; Shimizu A; Tatebayashi Y; Yamada H; Nakayama K; Kondo K
    Biochem Biophys Res Commun; 2013 Jan; 430(3):907-11. PubMed ID: 23261465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer's Disease.
    Faldu KG; Shah JS; Patel SS
    Recent Pat Antiinfect Drug Discov; 2015; 10(2):76-83. PubMed ID: 25963683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Involvement of Varicella Zoster Virus in Alzheimer's Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.
    Cairns DM; Itzhaki RF; Kaplan DL
    J Alzheimers Dis; 2022; 88(3):1189-1200. PubMed ID: 35754275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.
    Bourgade K; Garneau H; Giroux G; Le Page AY; Bocti C; Dupuis G; Frost EH; Fülöp T
    Biogerontology; 2015 Feb; 16(1):85-98. PubMed ID: 25376108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
    Wozniak MA; Mee AP; Itzhaki RF
    J Pathol; 2009 Jan; 217(1):131-8. PubMed ID: 18973185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.
    Itzhaki RF
    J Alzheimers Dis; 2016 Oct; 54(4):1273-1281. PubMed ID: 27497484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Involvement in Alzheimer's Disease.
    Sait A; Angeli C; Doig AJ; Day PJR
    ACS Chem Neurosci; 2021 Apr; 12(7):1049-1060. PubMed ID: 33687205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HSV1 activity of brown algal polysaccharides and possible relevance to the treatment of Alzheimer's disease.
    Wozniak M; Bell T; Dénes Á; Falshaw R; Itzhaki R
    Int J Biol Macromol; 2015 Mar; 74():530-40. PubMed ID: 25583021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Viral Properties of Amyloid-β Peptides.
    Bourgade K; Dupuis G; Frost EH; Fülöp T
    J Alzheimers Dis; 2016 Oct; 54(3):859-878. PubMed ID: 27392871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How plausible is a link between HSV-1 infection and Alzheimer's disease?
    Agostini S; Clerici M; Mancuso R
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):275-8. PubMed ID: 24502805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of aberrant amyloid β and phosphorylated tau expression in herpes simplex virus-infected neurons of the trigeminal ganglia and brain.
    Tran DN; Bakx ATCM; van Dis V; Aronica E; Verdijk RM; Ouwendijk WJD
    Brain Pathol; 2022 Jul; 32(4):e13044. PubMed ID: 34913212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.
    Harris SA; Harris EA
    Front Aging Neurosci; 2018; 10():48. PubMed ID: 29559905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    Harris SA; Harris EA
    J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 1 and Alzheimer's disease: link and potential impact on treatment.
    Mancuso R; Sicurella M; Agostini S; Marconi P; Clerici M
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):715-731. PubMed ID: 31414935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.